Company News

Share this article:

Cortex Pharmaceuticals, a California-based manufacturer of drug therapies for psychiatric disorders and neurological diseases, announced an organizational restructuring that includes a 50% reduction in workforce. Cortex cited the current financial climate—specifically uncertain capital markets—as the reason for workforce reductions.  

 

Eye care company Alcon launched a website—www.patanase.com—in support of its Patanase nasal spray, a prescription drug indicated for the relief of symptoms associated with seasonal allergic rhinitis in patients 12 years and older.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.